• Strategy
  • Portfolio
  • People
  • Careers
  • News
  • Blog
  • Contact Us
Foresite News
Press Releases
Portfolio News

For press inquiries click here to contact us.

Yahoo Finance

Aimmune Therapeutics To Announce Phase 2 Data At EAACI Congress 2015 For Study Of Peanut Allergy Desensitization Treatment

June 13, 2016
GenomeWeb

10X Genomics Signs Asia-Pacific Distribution Deals

May 11, 2016
FierceBiotech

Pfizer Inks A $911M Discovery Pact With Greg Verdine’s WaVe Life Sciences

May 5, 2016
TheStreet

Acceleron, Celgene Seek to Replace Entrenched Anti-Anemia Drugs in MDS Treatment

April 16, 2016
FierceBiotech

10X Genomics Scoops Another $55M To Fuel Commercialization Of Long-Read Tech

March 21, 2016
FierceBiotech

Aimmune’s Peanut Allergy Drug Clears Phase II On The Way To A Pivotal Test

March 7, 2016
Fortune

Diabetes-Focused ‘Unicorn’ Intarcia Makes Its First-Ever Acquisition

September 24, 2015
FierceBiotech

Biotech Intarcia’s Diabetes-Treating Implant Tops Januvia In A Head-to-Head Test

August 19, 2015
Bloomberg

Intarcia’s Diabetes Implant Beats Januvia In Trial

August 18, 2015
The Wall Street Journal

Intarcia’s Diabetes Treatment Clears Key Test

August 18, 2015
Page 23 of 26« First«...10...2122232425...»Last »

Please see important disclaimers in the Terms section.


©2026 Foresite Capital Management, LLC. Site by GOODLAB

    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
    Close
    • News
    • Blog
    • Foresite Labs
    • Contact Us
    • Home
    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
      • Blog
      • Careers
      • Contact Us
      • Disclosures
      • Home
      • Legal Disclaimers
      • Pardes Biosciences Legend
      • Privacy Policy
      • Strategy
      • Terms

    ©[current_date] Foresite Capital Management, LLC.

    Site by Goodlab

    Close